| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.65 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |